Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00327951 · ClinicalTrials.gov registry record
Infant Weight Gain With Trisomy 21 and CAVC
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 46
- Enrollment target
NCT00327951 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 46 participants.
The verdict
NCT00327951 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 46 participants
- Enrollment target
Study Summary
Failure to thrive and difficulty gaining weight is a sign of uncompensated congestive heart failure (CHF). Infants with Trisomy 21 and complete atrioventricular canal defects (CAVC) frequently develop uncompensated CHF and weight gain failure pre-operatively. A weight of 5 kg has been suggested as optimal for timing of CAVC repair. A delay in surgical repair often occurs if weight gain stalls and reaches a plateau prior to reaching 5 kg. A retrospective review performed by Kogon, et al, of children undergoing surgery for VSD at CHOA at Egleston recently reported that age and weight at surgery may not, however, be associated with adverse surgical outcome. The purpose of this study is to determine the optimal timing for surgical correction of CAVC in Trisomy 21 infants based on reaching a plateau of failed weight gain despite maximal anti-congestive and nutritional therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2001-01 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00327951
The ClinicalTrials.gov registry entry for NCT00327951 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00327951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00327951 about?
NCT00327951 is a clinical study titled "Infant Weight Gain With Trisomy 21 and CAVC". Failure to thrive and difficulty gaining weight is a sign of uncompensated congestive heart failure (CHF). Infants with Trisomy 21 and complete atrioventricular canal defects (CAVC) frequently develop uncompensated CHF and weight gain failure pre-operatively. A weight of 5 kg has been suggested as o...
What is the current status of trial NCT00327951?
This trial is currently terminated. The enrollment target is 46 participants. The study started on 2001-01. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00327951?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.